Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

2′,2′-Difluorodeoxyuridine

2’,2’-Difluorodeoxyuridine (dFdU) is the main metabolite of Gemcitabine (HY-17026) . 2’,2’-Difluorodeoxyuridine causes a concentration- and schedule- dependent radiosensitising effect in vitro. 2’,2’-Difluorodeoxyuridine arrests cell cycle at the early S phase and induces apoptosis in cancer cells[1][2][3].

Product Specifications

CAS Number

[114248-23-6]

Product Name Alternative

DFdU; 2',2'-Difluoro-2'-deoxyuridine

UNSPSC

12352005

Hazard Statement

H315, H319, H335

Target

Apoptosis; Drug Metabolite

Type

Reference compound

Related Pathways

Apoptosis; Metabolic Enzyme/Protease

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/2-2-difluorodeoxyuridine.html

Purity

99.87

Solubility

DMSO : 125 mg/mL (ultrasonic) |H2O : 100 mg/mL (ultrasonic)

Smiles

O=C(N1)N([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)C=CC1=O

Molecular Formula

C9H10F2N2O5

Molecular Weight

264.18

Precautions

H315, H319, H335

References & Citations

[1]Pauwels B, et al. The radiosensitising effect of difluorodeoxyuridine, a metabolite of gemcitabine, in vitro. Cancer Chemother Pharmacol. 2006 Aug;58 (2) :219-28.|[2]Veltkamp SA, et al. New insights into the pharmacology and cytotoxicity of gemcitabine and 2',2'-difluorodeoxyuridine. Mol Cancer Ther. 2008 Aug;7 (8) :2415-25.|[3]Veltkamp SA, et al. Extensive metabolism and hepatic accumulation of gemcitabine after multiple oral and intravenous administration in mice. Drug Metab Dispos. 2008 Aug;36 (8) :1606-15.

Shipping Conditions

Blue Ice

Storage Conditions

-20°C, 3 years (Powder)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

IHPK3 (IP6K3) (NM_001142883) Human Tagged ORF Clone Lentiviral Particle
RC227180L4V 200 µL

IHPK3 (IP6K3) (NM_001142883) Human Tagged ORF Clone Lentiviral Particle

Ask
View Details
SAPS3 antibody
70R-20083 50 ul

SAPS3 antibody

Ask
View Details
Docosanoic acid-13C4
HY-W013049S6 1 mg

Docosanoic acid-13C4

Ask
View Details